U.S. federal trademark · Serial No. 88082170 · Reg. No. UK0000333242
Pharmaceutical preparations for use in the treatment of myelofibrosis, polycythemia vera, autoinflammatory disease, autoimmune disease, blood disease, cancer, arthritis, musculoskeletal and skin diseases in the fields of oncology, immunology and inflammation; pharmaceutical preparations, namely, cytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.